(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-01-29 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1158690
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Wed Jan 2025 | 55.83 | 56.03 | 56.74 | 55.12 | 0.726 times |
| 28 Tue Jan 2025 | 56.00 | 55.97 | 56.82 | 55.66 | 1.065 times |
| 27 Mon Jan 2025 | 55.86 | 55.69 | 57.25 | 55.24 | 0.789 times |
| 24 Fri Jan 2025 | 55.77 | 55.29 | 56.08 | 54.98 | 0.632 times |
| 23 Thu Jan 2025 | 55.63 | 55.22 | 55.87 | 54.96 | 0.807 times |
| 22 Wed Jan 2025 | 55.28 | 55.79 | 56.00 | 54.99 | 0.996 times |
| 21 Tue Jan 2025 | 55.94 | 55.10 | 56.39 | 54.88 | 1.039 times |
| 17 Fri Jan 2025 | 54.80 | 55.66 | 55.73 | 54.77 | 0.813 times |
| 17 Fri Jan 2025 | 54.80 | 55.66 | 55.73 | 54.77 | 0.813 times |
| 16 Thu Jan 2025 | 55.37 | 54.64 | 55.79 | 54.64 | 1.355 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 56.2 as stoploss in an intra day sell trade for a target of 53.78. However, stock will show a bullish move above 56.2.
Share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Target | 42.01 |
| Downside Target | 46.39 |
| Downside Target | 47.52 |
| Downside Target | 48.84 |
| Downside Target | 51.91 |
| Downside Target | 54.77 |
| Downside Target | 55.79 |
| Upside Target | 56.39 |
| Upside Target | 57.25 |
| Upside Target | 62.00 |
| Upside Target | 62.13 |
| Upside Target | 64.18 |
Intraday share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Intraday Target | 54.88 |
| Downside Intraday Target | 53.94 |
| Upside Intraday Target | 57.01 |
| Upside Intraday Target | 58.2 |
| Upside Intraday Target | 56.07 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Wed Jan 2025 | 55.83 | 55.69 | 57.25 | 55.12 | 0.742 times |
| 24 Fri Jan 2025 | 55.77 | 55.10 | 56.39 | 54.88 | 4.273 times |
| 17 Fri Jan 2025 | 54.80 | 55.66 | 55.73 | 54.77 | 0.12 times |
| 17 Fri Jan 2025 | 54.80 | 52.65 | 55.79 | 52.23 | 1.63 times |
| 10 Fri Jan 2025 | 52.80 | 54.12 | 55.00 | 51.91 | 0.758 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Wed Jan 2025 | 55.83 | 48.23 | 57.25 | 47.52 | 1.381 times |
| 31 Tue Dec 2024 | 47.81 | 48.20 | 49.79 | 46.39 | 0.444 times |
| 26 Tue Nov 2024 | 47.79 | 55.66 | 62.13 | 42.01 | 1.548 times |
| 31 Thu Oct 2024 | 50.57 | 56.97 | 62.00 | 48.84 | 1.161 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term and the buy signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.53 and Halozyme Therapeutics (HALO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Halozyme Therapeutics in short term and the buy signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 55.53 and Halozyme Therapeutics (HALO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.